Chronicle Journal: Finance

Drugmaker Mylan's 4th-qtr profit rises on strong demand in N. America

March 2 (Reuters) - Generic and specialty drugmaker Mylan Inc reported a rise in quarterly profit and revenue, driven mainly by strong demand for its generics in North America.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.